Emergent BioSolutions Inc.
EBS
39 insider filings · Latest: Jul 1, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 23, 2025 | May 23 8:04 PM | KEITH KATKIN | Proposed Sale | 7,844 | $6.30 | $49.4K | — | View → |
| Mar 12, 2025 | Mar 12 9:34 PM | Fowler Neal Franklin | Proposed Sale | 35,000 | $5.83 | $204.0K | — | View → |
| Mar 12, 2025 | Mar 12 9:23 PM | Zoon Kathryn C | Proposed Sale | 10,000 | $5.73 | $57.3K | — | View → |
| Nov 12, 2024 | Nov 12 10:16 PM | DeGolyer Donald W | Proposed Sale | 25,000 | $11.77 | $294.3K | — | View → |
| Nov 11, 2024 | Nov 12 3:34 PM | White Marvin L | Proposed Sale | 14,287 | $11.77 | $168.2K | — | View → |
← Previous
Page 2 of 2
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | May 4 9:30 PM | Sujata Tyagi DayalDirector | Grant/Award | 11,296 | $7.99 | 11,296(D) | View → |
| Apr 30, 2026 | May 4 9:30 PM | Donald W DegolyerDirector | Grant/Award | 11,296 | $7.99 | 11,296(D) | View → |
| Apr 30, 2026 | May 4 9:29 PM | Keith KatkinDirector | Grant/Award | 11,296 | $7.99 | 11,296(D) | View → |
| Apr 30, 2026 | May 4 9:29 PM | Marvin L WhiteDirector | Grant/Award | 11,296 | $7.99 | 11,296(D) | View → |
| Apr 30, 2026 | May 4 9:29 PM | John D Fowler JRDirector | Grant/Award | 11,296 | $7.99 | 11,296(D) | View → |
| Apr 30, 2026 | May 4 9:28 PM | Ronald RichardDirector | Grant/Award | 11,296 | $7.99 | 11,296(D) | View → |
| Apr 30, 2026 | May 4 9:28 PM | Kathryn C ZoonDirector | Grant/Award | 11,296 | $7.99 | 11,296(D) | View → |
| Apr 30, 2026 | May 4 9:27 PM | Neal Franklin FowlerDirector | Grant/Award | 11,296 | $7.99 | 11,296(D) | View → |
| Apr 30, 2026 | May 4 9:23 PM | Zsolt HarsanyiDirector, Chairman | Grant/Award | 11,296 | $7.99 | 11,296(D) | View → |
| Feb 25, 2026 | Mar 6 1:50 PM | Richard S LindahlEVP, Chief Financial Officer | H | 20,321 | $61.01 | 0(D) | View → |
| May 7, 2025 | Mar 6 1:50 PM | Richard S LindahlEVP, Chief Financial Officer | H | 19,963 | $48.33 | 0(D) | View → |
| Mar 3, 2026 | Mar 6 2:40 AM | Joseph C PapaDirector, President and CEO | Grant/Award | 252,194 | $8.99 | 1,784,694(D) | View → |
| Mar 3, 2026 | Mar 6 2:21 AM | Simon C LowrySVP, R&D, CMO | Grant/Award | 44,834 | $8.99 | 147,833(D) | View → |
| Mar 3, 2026 | Mar 6 2:20 AM | William HartzelSVP, Bioservices | Grant/Award | 44,834 | $8.99 | 259,545(D) | View → |
| Mar 3, 2026 | Mar 6 2:19 AM | Jessica PerlSVP, General Counsel, Corp Sec | Grant/Award | 46,702 | $8.99 | 142,647(D) | View → |
| Mar 3, 2026 | Mar 6 2:08 AM | Paul Anthony WilliamsSVP, Products Business | Grant/Award | 44,834 | $8.99 | 254,948(D) | View → |
| Mar 3, 2026 | Mar 6 2:07 AM | Richard S LindahlEVP, Chief Financial Officer | Grant/Award | 72,856 | $8.99 | 557,346(D) | View → |
| Mar 3, 2026 | Mar 6 2:06 AM | Coleen GlessnerEVP, Quality & Ethics, and CPL | Grant/Award | 44,834 | $8.99 | 294,447(D) | View → |